John Michailidis addressed the audience at the recent Naevus Support Australia national conference

John Michailidis addressed the audience at the recent Naevus Support Australia national conference about the new Veil Cosmetic Camouflage range of products exclusively distributed by JEM Pharmaceuticals. Veil is the UK’s number one cosmetic camouflage and is effective in camouflaging a wide range of vascular skin malformations.

Congenital Melanocytic Naevi are a rare skin malformation affecting 1 in 20,000 newborns. Veil is an effective adjunct to the management of this and many other common skin malformations.

Michelle Sibbons, Director & Naevus Support Australia with John Michailidis, Managing Director – JEM Pharmaceuticals

Michelle Sibbons, Director & Naevus Support Australia with John Michailidis, Managing Director @ JEM Pharmaceuticals

© Copyright 2019 JEM Pharmaceuticals Pty Ltd

Interface Design by Think Soda